A recent review published in the journal Engineering delves into the significant advancements and potential of CRISPR ...

Advances in the gene-editing technology known as CRISPR-Cas9 over the past 15 years have yielded important new insights into the roles that specific genes play in many diseases. But to date this ...

CRISPR Therapeutics AG (CRSP) closed the latest trading day at $41.22, indicating a +0.12% change from the previous session's end. This change outpaced the S&P 500's 0.08% gain on the day. On the ...

Bioengineering professor and The Grainger College of Engineering's Dean, Rashid Bashir, led a team of researchers in a ...

Ben Hargreaves provides an overview of the treatment, and expands to examine other areas where CRISPR tools could make a major medical difference ... only boosts CRISPR technology’s reputation ...

CRISPR Therapeutics' stock faces challenges with slow Casgevy adoption and competition. See how CRSP stock remains a cautious ...

CRISPR gene-editing technology offers the possibility of creating disease-resistant species, potentially eliminating deadly ...

University of Illinois at Urbana-Champaign researchers have developed a CRISPR-based diagnostic tool capable of detecting ...

Researchers at Kumamoto University have successfully executed a practical trial of a new genome-editing technique that allows ...

While technology and medicine have ... There is no doubt that CRISPR and CAR-T cell therapy are breakthroughs in the medical field. But because they are still in their initial stages, they come ...

The researchers applied CRISPR gene technology to investigate whether activating an entire ... Gene and Cell Therapy and induction as a Fellow of the American Institute for Medical and Biological ...

The Cambridge-based company touted the data as evidence of the first successful use of CRISPR gene editing to fix a ...